CIVAX
Price
$16.39
Change
-$0.37 (-2.21%)
Updated
Dec 18 closing price
RERAX
Price
$53.07
Change
-$1.17 (-2.16%)
Updated
Dec 18 closing price
Ad is loading...

CIVAX vs RERAX

Header iconCIVAX vs RERAX Comparison
Open Charts CIVAX vs RERAXBanner chart's image
American Funds International Vntg 529-A
Price$16.39
Change-$0.37 (-2.21%)
VolumeN/A
CapitalizationN/A
American Funds Europacific Growth R1
Price$53.07
Change-$1.17 (-2.16%)
VolumeN/A
CapitalizationN/A
CIVAX vs RERAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CIVAX vs. RERAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CIVAX is a StrongBuy and RERAX is a StrongSell.

FUNDAMENTALS
Fundamentals
RERAX has more cash in the bank: 131B vs. CIVAX (2.04B). CIVAX pays higher dividends than RERAX: CIVAX (1.10) vs RERAX (0.91). CIVAX was incepted earlier than RERAX: CIVAX (5 years) vs RERAX (23 years). RERAX is a more actively managed with annual turnover of: 34.00 vs. CIVAX (15.00). CIVAX (250) and RERAX (250) have matching initial minimum investment requirements. CIVAX annual gain was more profitable for investors over the last year : 6.39 vs. RERAX (4.26). CIVAX return over 5 years is better than : 22.63 vs. RERAX (2.29).
CIVAXRERAXCIVAX / RERAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years23 years-
Gain YTD4.2993.168136%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets2.04B131B2%
Annual Yield % from dividends1.100.91120%
Returns for 1 year6.394.26150%
Returns for 3 years3.54-8.95-39%
Returns for 5 years22.632.29989%
Returns for 10 yearsN/A18.36-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSAQX22.370.13
+0.58%
Morgan Stanley Inst Asia Opp I
MSEQX61.680.23
+0.37%
Morgan Stanley Inst Growth I
WOOQX19.14-0.19
-0.98%
JPMorgan SMID Cap Equity R4
EEMGX8.09-0.09
-1.10%
MFS Emerging Markets Equity Research R4
NINLX22.30-0.31
-1.37%
Neuberger Berman Intrinsic Value I